ZGEN - now we've sorted out the accounting trivia, can we chat about value relative to price? My gut says it's about fairly valued, but my brain has not done any work on the question.
Does anyone else wonder if Zymo SGA spend on Recothrom is really justified?
And does anyone else miss Bruce Carter's voice on the CCs?
Market Data 
Markets 
AI
